Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Jöbsis Q[au]:

A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Horváth I et al. Eur Respir J. (2017)

Biomarkers to predict asthma in wheezing preschool children. Bannier MA et al. Clin Exp Allergy. (2015)

Introduction of a new paediatric asthma guideline: Effects on asthma control levels. Hammer SC et al. Pediatr Allergy Immunol. (2017)

Search results

Items: 1 to 50 of 65

1.

Exhaled Breath Condensate in Childhood Asthma: A Review and Current Perspective.

Bannier MAGE, Rosias PPR, Jöbsis Q, Dompeling E.

Front Pediatr. 2019 Apr 25;7:150. doi: 10.3389/fped.2019.00150. eCollection 2019. Review.

2.

Publisher Correction: Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function.

van Horck M, Winkens B, Wesseling G, van Vliet D, van de Kant K, Vaassen S, de Winter-de Groot K, de Vreede I, Jöbsis Q, Dompeling E.

Sci Rep. 2018 Dec 13;8(1):17946. doi: 10.1038/s41598-018-36407-y.

3.

Feasibility and diagnostic accuracy of an electronic nose in children with asthma and cystic fibrosis.

Bannier MAGE, van de Kant KDG, Jöbsis Q, Dompeling E.

J Breath Res. 2019 May 8;13(3):036009. doi: 10.1088/1752-7163/aae158.

PMID:
30213921
4.

Risk factors for lung disease progression in children with cystic fibrosis.

van Horck M, van de Kant K, Winkens B, Wesseling G, Gulmans V, Hendriks H, van der Grinten C, Jöbsis Q, Dompeling E.

Eur Respir J. 2018 Jun 7;51(6). pii: 1702509. doi: 10.1183/13993003.02509-2017. Print 2018 Jun.

PMID:
29773689
5.

Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function.

van Horck M, Winkens B, Wesseling G, van Vliet D, van de Kant K, Vaassen S, de Winter-de Groot K, de Vreede I, Jöbsis Q, Dompeling E.

Sci Rep. 2017 Sep 27;7(1):12350. doi: 10.1038/s41598-017-10945-3. Erratum in: Sci Rep. 2018 Dec 13;8(1):17946.

6.

Factors associated with changes in health-related quality of life in children with cystic fibrosis during 1-year follow-up.

van Horck M, Winkens B, Wesseling G, de Winter-de Groot K, de Vreede I, Jöbsis Q, Dompeling E.

Eur J Pediatr. 2017 Aug;176(8):1047-1054. doi: 10.1007/s00431-017-2928-6. Epub 2017 Jun 9.

7.

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.

Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, Boots AW, Bos LD, Brinkman P, Bucca C, Carpagnano GE, Corradi M, Cristescu S, de Jongste JC, Dinh-Xuan AT, Dompeling E, Fens N, Fowler S, Hohlfeld JM, Holz O, Jöbsis Q, Van De Kant K, Knobel HH, Kostikas K, Lehtimäki L, Lundberg J, Montuschi P, Van Muylem A, Pennazza G, Reinhold P, Ricciardolo FLM, Rosias P, Santonico M, van der Schee MP, van Schooten FJ, Spanevello A, Tonia T, Vink TJ.

Eur Respir J. 2017 Apr 26;49(4). pii: 1600965. doi: 10.1183/13993003.00965-2016. Print 2017 Apr.

8.

Introduction of a new paediatric asthma guideline: Effects on asthma control levels.

Hammer SC, Sonneveld LJH, van de Kant KDG, Hendriks HJ, Heynens JW, Droog R, Dompeling E, Jöbsis Q.

Pediatr Allergy Immunol. 2017 May;28(3):266-272. doi: 10.1111/pai.12697. Epub 2017 Mar 28.

PMID:
28107572
9.

Can exhaled volatile organic compounds predict asthma exacerbations in children?

van Vliet D, Smolinska A, Jöbsis Q, Rosias P, Muris J, Dallinga J, Dompeling E, van Schooten FJ.

J Breath Res. 2017 Mar 1;11(1):016016. doi: 10.1088/1752-7163/aa5a8b.

PMID:
28102830
10.

Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.

van Horck M, Alonso A, Wesseling G, de Winter-de Groot K, van Aalderen W, Hendriks H, Winkens B, Rijkers G, Jöbsis Q, Dompeling E.

PLoS One. 2016 Apr 6;11(4):e0152156. doi: 10.1371/journal.pone.0152156. eCollection 2016.

11.

Association between exhaled inflammatory markers and asthma control in children.

Van Vliet D, Smolinska A, Jöbsis Q, Rosias PP, Muris JW, Dallinga JW, van Schooten FJ, Dompeling E.

J Breath Res. 2016 Feb 19;10(1):016014. doi: 10.1088/1752-7155/10/1/016014.

PMID:
26893372
12.

Prediction of asthma exacerbations in children by innovative exhaled inflammatory markers: results of a longitudinal study.

van Vliet D, Alonso A, Rijkers G, Heynens J, Rosias P, Muris J, Jöbsis Q, Dompeling E.

PLoS One. 2015 Mar 23;10(3):e0119434. doi: 10.1371/journal.pone.0119434. eCollection 2015.

13.

An ADAM33 polymorphism associates with progression of preschool wheeze into childhood asthma: a prospective case-control study with replication in a birth cohort study.

Klaassen EM, Penders J, Jöbsis Q, van de Kant KD, Thijs C, Mommers M, van Schayck CP, van Eys G, Koppelman GH, Dompeling E.

PLoS One. 2015 Mar 13;10(3):e0119349. doi: 10.1371/journal.pone.0119349. eCollection 2015.

14.

Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age.

Klaassen EM, van de Kant KD, Jöbsis Q, van Schayck OC, Smolinska A, Dallinga JW, van Schooten FJ, den Hartog GJ, de Jongste JC, Rijkers GT, Dompeling E.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):201-7. doi: 10.1164/rccm.201408-1537OC.

PMID:
25474185
15.

Biomarkers to predict asthma in wheezing preschool children.

Bannier MA, van de Kant KD, Jöbsis Q, Dompeling E.

Clin Exp Allergy. 2015 Jun;45(6):1040-50. doi: 10.1111/cea.12460. Review.

PMID:
25409553
16.

CD14/Toll-like receptors interact with bacteria and regulatory T-cells in the development of childhood asthma.

Klaassen EM, van de Kant KD, Soeteman M, Damoiseaux J, van Eys G, Stobberingh EE, Stelma FF, Quaak M, van Schayck OC, Jöbsis Q, Dompeling E.

Eur Respir J. 2014 Sep;44(3):799-802. doi: 10.1183/09031936.00020314. Epub 2014 Jul 17. No abstract available.

17.

Electronic monitoring of symptoms and lung function to assess asthma control in children.

van Vliet D, van Horck M, van de Kant K, Vaassen S, Gulikers S, Winkens B, Rosias P, Heynens J, Muris J, Essers B, Jöbsis Q, Dompeling E.

Ann Allergy Asthma Immunol. 2014 Sep;113(3):257-262.e1. doi: 10.1016/j.anai.2014.05.015. Epub 2014 Jun 18.

PMID:
24950912
18.

Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.

Smolinska A, Klaassen EM, Dallinga JW, van de Kant KD, Jobsis Q, Moonen EJ, van Schayck OC, Dompeling E, van Schooten FJ.

PLoS One. 2014 Apr 21;9(4):e95668. doi: 10.1371/journal.pone.0095668. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105447.

19.

Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma.

Klaassen EM, van de Kant KD, Jöbsis Q, Penders J, van Schooten FJ, Quaak M, den Hartog GJ, Koppelman GH, van Schayck CP, van Eys G, Dompeling E.

Pediatr Allergy Immunol. 2014 Mar;25(2):166-72. doi: 10.1111/pai.12187. Epub 2014 Jan 6.

PMID:
24393359
20.

Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study.

Robroeks CM, van Berkel JJ, Jöbsis Q, van Schooten FJ, Dallinga JW, Wouters EF, Dompeling E.

Eur Respir J. 2013 Jul;42(1):98-106. doi: 10.1183/09031936.00010712. Epub 2013 May 3.

21.

A systematic review of CD14 and toll-like receptors in relation to asthma in Caucasian children.

Klaassen EM, Thönissen BE, van Eys G, Dompeling E, Jöbsis Q.

Allergy Asthma Clin Immunol. 2013 Mar 15;9(1):10. doi: 10.1186/1710-1492-9-10.

22.

Symptoms, but not a biomarker response to inhaled corticosteroids, predict asthma in preschool children with recurrent wheeze.

Klaassen EM, van de Kant KD, Jöbsis Q, Høvig ST, van Schayck CP, Rijkers GT, Dompeling E.

Mediators Inflamm. 2012;2012:162571. doi: 10.1155/2012/162571. Epub 2012 Dec 5.

23.

Exhaled breath profiling in diagnosing wheezy preschool children.

van de Kant KD, van Berkel JJ, Jöbsis Q, Lima Passos V, Klaassen EM, van der Sande L, van Schayck OC, de Jongste JC, van Schooten FJ, Derks E, Dompeling E, Dallinga JW.

Eur Respir J. 2013 Jan;41(1):183-8. doi: 10.1183/09031936.00122411.

24.

Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

van de Kant KD, van der Sande LJ, Jöbsis Q, van Schayck OC, Dompeling E.

Respir Res. 2012 Dec 21;13:117. doi: 10.1186/1465-9921-13-117. Review.

25.

Impact of bacterial colonization on exhaled inflammatory markers in wheezing preschool children.

van de Kant KD, Klaassen EM, van Aerde KJ, Damoiseaux J, Bruggeman CA, Stelma FF, Stobberingh EE, Muris JW, Jöbsis Q, van Schayck OC, Dompeling E.

J Breath Res. 2012 Dec;6(4):046001. doi: 10.1088/1752-7155/6/4/046001. Epub 2012 Sep 18. Erratum in: J Breath Res. 2012 Dec;6(4):049601.

PMID:
22990010
26.

Prediction of asthma exacerbations in children: results of a one-year prospective study.

Robroeks CM, van Vliet D, Jöbsis Q, Braekers R, Rijkers GT, Wodzig WK, Bast A, Zimmermann LJ, Dompeling E.

Clin Exp Allergy. 2012 May;42(5):792-8. doi: 10.1111/j.1365-2222.2012.03992.x.

PMID:
22515395
27.

Elevated inflammatory markers at preschool age precede persistent wheezing at school age.

van de Kant KD, Jansen MA, Klaassen EM, van der Grinten CP, Rijkers GT, Muris JW, van Schayck OC, Jöbsis Q, Dompeling E.

Pediatr Allergy Immunol. 2012 May;23(3):259-64. doi: 10.1111/j.1399-3038.2011.01244.x. Epub 2011 Dec 23.

PMID:
22192238
28.

Can exhaled inflammatory markers predict a steroid response in wheezing preschool children?

van de Kant KD, Koers K, Rijkers GT, Lima Passos V, Klaassen EM, Mommers M, Dagnelie PC, van Schayck CP, Dompeling E, Jöbsis Q.

Clin Exp Allergy. 2011 Aug;41(8):1076-83. doi: 10.1111/j.1365-2222.2011.03774.x. Epub 2011 May 30.

PMID:
21623968
29.

Proteomics of exhaled breath condensate: a realistic approach in children with asthma?

Dompeling E, Jöbsis Q.

Clin Exp Allergy. 2011 Mar;41(3):299-301. doi: 10.1111/j.1365-2222.2010.03686.x. No abstract available.

PMID:
21294783
30.

Feasibility of exhaled nitric oxide measurements at various flow rates in children with asthma.

Robroeks CM, van Vliet D, Hendriks HJ, Dompeling E, Jöbsis Q.

Pediatr Allergy Immunol. 2010 Feb;21(1 Pt 2):e222-8. doi: 10.1111/j.1399-3038.2009.00874.x.

PMID:
21083853
31.

Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate.

van de Kant KD, Klaassen EM, Jöbsis Q, Koers K, Rijkers GT, van der Grinten CP, van Schayck OC, Passos VL, Dompeling E.

J Allergy Clin Immunol. 2010 Sep;126(3):669-71. doi: 10.1016/j.jaci.2010.07.013. No abstract available.

PMID:
20816200
32.

Structural lung changes, lung function, and non-invasive inflammatory markers in cystic fibrosis.

Robroeks CM, Roozeboom MH, de Jong PA, Tiddens HA, Jöbsis Q, Hendriks HJ, Yntema JB, Brackel HL, van Gent R, Robben S, Dompeling E.

Pediatr Allergy Immunol. 2010 May;21(3):493-500. doi: 10.1111/j.1399-3038.2009.00872.x.

PMID:
20546526
33.

Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.

Robroeks CM, van Berkel JJ, Dallinga JW, Jöbsis Q, Zimmermann LJ, Hendriks HJ, Wouters MF, van der Grinten CP, van de Kant KD, van Schooten FJ, Dompeling E.

Pediatr Res. 2010 Jul;68(1):75-80. doi: 10.1203/00006450-201011001-00143.

PMID:
20351658
34.

Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children.

Robroeks CM, Rijkers GT, Jöbsis Q, Hendriks HJ, Damoiseaux JG, Zimmermann LJ, van Schayck OP, Dompeling E.

Clin Exp Allergy. 2010 Jan;40(1):77-84. doi: 10.1111/j.1365-2222.2009.03397.x.

PMID:
20205697
35.

Instructiveness of real patients and simulated patients in undergraduate medical education: a randomized experiment.

Bokken L, Rethans JJ, Jöbsis Q, Duvivier R, Scherpbier A, van der Vleuten C.

Acad Med. 2010 Jan;85(1):148-54. doi: 10.1097/ACM.0b013e3181c48130.

PMID:
20042841
36.

Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children.

Dallinga JW, Robroeks CM, van Berkel JJ, Moonen EJ, Godschalk RW, Jöbsis Q, Dompeling E, Wouters EF, van Schooten FJ.

Clin Exp Allergy. 2010 Jan;40(1):68-76. doi: 10.1111/j.1365-2222.2009.03343.x. Epub 2009 Sep 28.

PMID:
19793086
37.

Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study.

van de Kant KD, Klaassen EM, Jöbsis Q, Nijhuis AJ, van Schayck OC, Dompeling E.

BMC Public Health. 2009 Jun 29;9:210. doi: 10.1186/1471-2458-9-210.

38.

Feasibility of a new method to collect exhaled breath condensate in pre-school children.

Rosias PP, Robroeks CM, van de Kant KD, Rijkers GT, Zimmermann LJ, van Schayck CP, Heynens JW, Jöbsis Q, Dompeling E.

Pediatr Allergy Immunol. 2010 Feb;21(1 Pt 2):e235-44. doi: 10.1111/j.1399-3038.2009.00909.x. Epub 2009 Jun 26.

PMID:
19563465
39.

A 3-year-old female with cough, dyspnoea and low-grade fever.

Been JV, Robben SG, Delhaas T, Theunissen P, Dompeling E, Jöbsis Q.

Eur Respir J. 2009 Mar;33(3):690-3. doi: 10.1183/09031936.00074108. No abstract available.

40.

Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma.

Robroeks CM, van de Kant KD, van Vliet D, Kester AD, Hendriks HJ, Damoiseaux JG, Wodzig WK, Rijkers GT, Dompeling E, Jöbsis Q.

Ann Allergy Asthma Immunol. 2008 Jun;100(6):601-7. doi: 10.1016/S1081-1206(10)60052-X.

PMID:
18592826
41.

Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children.

Robroeks CM, Rosias PP, van Vliet D, Jöbsis Q, Yntema JB, Brackel HJ, Damoiseaux JG, den Hartog GM, Wodzig WK, Dompeling E.

Pediatr Allergy Immunol. 2008 Nov;19(7):652-9. doi: 10.1111/j.1399-3038.2007.00693.x. Epub 2008 Feb 27.

PMID:
18312532
42.

Global condensation: a "climate change" towards better standardisation of exhaled breath condensate measurements.

Rosias PP, Jöbsis Q, van de Kant K, Robroeks C, van Schayck CP, Zimmermann LJ, Dompeling E.

Eur Respir J. 2008 Mar;31(3):684-5. doi: 10.1183/09031936.00157907. No abstract available.

43.

Actual asthma control in a paediatric outpatient clinic population: do patients perceive their actual level of control?

Hammer SC, Robroeks CM, van Rij C, Heynens J, Droog R, Jöbsis Q, Hendriks HJ, Dompeling E.

Pediatr Allergy Immunol. 2008 Nov;19(7):626-33. doi: 10.1111/j.1399-3038.2007.00705.x. Epub 2008 Jan 22.

PMID:
18221469
44.

Biomarker reproducibility in exhaled breath condensate collected with different condensers.

Rosias PP, Robroeks CM, Kester A, den Hartog GJ, Wodzig WK, Rijkers GT, Zimmermann LJ, van Schayck CP, Jöbsis Q, Dompeling E.

Eur Respir J. 2008 May;31(5):934-42. doi: 10.1183/09031936.00073207. Epub 2008 Jan 9.

45.

Effects of tobacco exposure on lung health and pulmonary biomarkers in young, healthy smokers aged 12-25 years: a systematic review.

Kotz D, van de Kant K, Jöbsis Q, van Schayck CP.

Expert Rev Respir Med. 2007 Dec;1(3):403-18. doi: 10.1586/17476348.1.3.403.

PMID:
20477179
46.

Exhaled nitric oxide and biomarkers in exhaled breath condensate indicate the presence, severity and control of childhood asthma.

Robroeks CM, van de Kant KD, Jöbsis Q, Hendriks HJ, van Gent R, Wouters EF, Damoiseaux JG, Bast A, Wodzig WK, Dompeling E.

Clin Exp Allergy. 2007 Sep;37(9):1303-11.

PMID:
17845410
47.

Free radicals in exhaled breath condensate in cystic fibrosis and healthy subjects.

Rosias PP, Den Hartog GJ, Robroeks CM, Bast A, Donckerwolcke RA, Heynens JW, Suykerbuyk J, Hendriks HJ, Jöbsis Q, Dompeling E.

Free Radic Res. 2006 Sep;40(9):901-9.

PMID:
17015269
48.

Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate.

Rosias PP, Robroeks CM, Niemarkt HJ, Kester AD, Vernooy JH, Suykerbuyk J, Teunissen J, Heynens J, Hendriks HJ, Jöbsis Q, Dompeling E.

Eur Respir J. 2006 Nov;28(5):1036-41. Epub 2006 Jul 26.

49.

Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis.

Robroeks CM, Jöbsis Q, Damoiseaux JG, Heijmans PH, Rosias PP, Hendriks HJ, Dompeling E.

Ann Allergy Asthma Immunol. 2006 Feb;96(2):349-55.

PMID:
16498859
50.

Exhaled breath condensate: methodological recommendations and unresolved questions.

Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, Jöbsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H; ATS/ERS Task Force on Exhaled Breath Condensate.

Eur Respir J. 2005 Sep;26(3):523-48.

Supplemental Content

Loading ...
Support Center